Drug Profile
Clopidogrel - Sanofi
Alternative Names: DV-7314; Iscover; PCR 4099; Plavix; SR 25989C; SR 25990CLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator sanofi-aventis
- Developer Bristol-Myers Squibb; Sanofi
- Class 2 ring heterocyclic compounds; Anti-ischaemics; Antiplatelets; Antithrombotics; Cardiovascular therapies; Chlorobenzenes; Esters; Ischaemic heart disorder therapies; Pyridines; Small molecules; Thienopyridines; Vascular disorder therapies
- Mechanism of Action Platelet ADP receptor antagonists; Platelet aggregation inhibitors; Purinergic P2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Acute coronary syndromes; Angina pectoris; Atherosclerosis; Cardiovascular disorders; Ischaemic heart disorders; Myocardial infarction; Peripheral arterial occlusive disorders; Stroke; Unstable angina pectoris
- Discontinued Congenital heart defects; Coronary thrombosis